ReviewSignal transduction and targeted therapy2026
Neuro-immune interactions in tumors, immune-related disorders, and infections.
Review in Signal transduction and targeted therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The nervous and immune systems interact to form a complex network that sustains homeostasis and finely tunes immune responses. These interactions significantly influence the pathogenesis and progression of various diseases, such as tumors, immune-related disorders, and infections. Consequently, these interactions have become promising therapeutic targets. However, insufficient mechanistic research and the lack of candidate drugs have restricted the application of therapeutic strategies targeting neuro-immune interactions. In this review, we summarize three modes of neuro-immune interactions: local mechanisms, reflex-level organization, and central nervous system-wide regulation. Next, we elucidate the mechanisms of neuro-immune interactions across different diseases, discuss their variations, and highlight the spatiotemporal heterogeneity of these interactions. Additionally, understanding the dynamic crosstalk between specific neuronal and immune cell subtypes could reveal novel biomarkers and intervention points, facilitating more precise and personalized therapeutic strategies in diverse disease contexts. Furthermore, we dissect the current status of clinical trials and analyze the major challenges hindering effective clinical translation. Finally, we explore the potential of high-throughput sequencing technologies, such as single-cell omics and spatial omics, as well as neuro-electrophysiological methods, for in-depth investigation of related mechanisms. By integrating preclinical and clinical perspectives, this review aims to provide valuable insights into the therapeutic potential and future directions in the burgeoning field of neuro-immune interactions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.